| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |